izpis_h1_title_alt

Interactome of PTH-Regulated miRNAs and their predicted target genes for Investigating the epigenetic effects of PTH (1–34) in bone metabolism
ID Vrščaj, Lucija Ana (Avtor), ID Marc, Janja (Avtor), ID Ostanek, Barbara (Avtor)

URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2073-4425/13/8/1443 Povezava se odpre v novem oknu
.pdfPDF - Predstavitvena datoteka, prenos (1,05 MB)
MD5: 11AEA578AD16B4EE294E40C81CB42B23

Izvleček
Osteoporosis is a metabolic bone disease that mostly affects the elderly. A lot of drugs are available, mostly with an antiresorptive effect but just a few with an osteoanabolic effect, meaning they promote bone building. PTH (1-34) or teriparatide is an osteoanabolic drug, but its efficacy varies between individuals. We performed a literature review and extracted a dataset of 62 microRNAs (miRNAs) from 10 different studies; predicted miRNA target interactions (MTIs) were obtained with the help of four software tools: DIANA, miRWalk, miRDB and TargetScan. With the construction of an interactome of PTH-regulated miRNAs and their predicted target genes, we elucidated miR-146a-5p, miR-551b-5p, miR-205-3p, miR-33a-3p, miR-338-5p as miRNAs with the most interactions and miR-410-3p as the miRNA targeting bone-related pathways with the highest significance. These miRNAs could help in further understanding the mechanism of action of PTH on bone metabolism and osteoporosis. They also have the potential for novel network-based biomarkers for osteoporosis treatment efficacy and safety and as new therapeutic targets.

Jezik:Angleški jezik
Ključne besede:osteoporosis, osteoporosis treatment, microRNA, parathyroid hormone, teriparatide, network, Cytoscape, biological pathway, gene enrichment biomarker
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Datum objave:13.08.2022
Leto izida:2022
Št. strani:Str. 1-15
Številčenje:Vol. 13, iss. 8, art. 1443
PID:20.500.12556/RUL-138758 Povezava se odpre v novem oknu
UDK:616.71-007.234:616-085
ISSN pri članku:2073-4425
DOI:10.3390/genes13081443 Povezava se odpre v novem oknu
COBISS.SI-ID:118226947 Povezava se odpre v novem oknu
Datum objave v RUL:16.08.2022
Število ogledov:345
Število prenosov:85
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Genes
Skrajšan naslov:Genes
Založnik:Multidisciplinary Digital Publishing Institute (MDPI)
ISSN:2073-4425
COBISS.SI-ID:523100185 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:16.08.2022

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:zdravljenje osteoporoze, mikroRNA, paratiroidni hormon, teriparatid, omrežje, biomarker za obogatitev genov, biološka pot

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0298
Naslov:Geni, hormonske in osebnostne spremembe pri metabolnih motnjah

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-1759
Naslov:Celostna karakterizacija zadetkov analiz GWAS - pot do novih terapevtskih tarč za anabolno zdravljenje osteoporoze(GWASforAna)

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj